These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7125797)

  • 21. Circulating immune complexes in patients with leprosy.
    Park JY; Kim KW; Kim SJ; Kim JD
    Yonsei Med J; 1984; 25(1):18-26. PubMed ID: 6544535
    [No Abstract]   [Full Text] [Related]  

  • 22. B lymphocytes in lepromatous leprosy.
    Gajl-Peczalska KJ; Lim SD; Jacobson RR; Good RA
    N Engl J Med; 1973 May; 288(20):1033-5. PubMed ID: 4572304
    [No Abstract]   [Full Text] [Related]  

  • 23. Serological abnormalities in Japanese patients with borderline leprosy.
    Furukawa F; Kohno A; Hamashima Y
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):96-8. PubMed ID: 6608504
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies of circulating immune complexes in ankylosing spondylitis.
    Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
    Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy.
    Furukawa F; Ozaki M; Imamura S; Yoshida H; Pinrat A; Hamashima Y
    Arch Dermatol Res; 1982; 274(1-2):185-8. PubMed ID: 7165365
    [No Abstract]   [Full Text] [Related]  

  • 26. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Circulating immune complexes in pulmonary tuberculosis].
    Chernushenko EF; Sereda NN
    Vrach Delo; 1982 Sep; (9):94-5. PubMed ID: 7179926
    [No Abstract]   [Full Text] [Related]  

  • 28. [An autopsy case of primary myelofibrosis with high value of circulating immune complexes, IgG(kappa) monoclonal gammopathy and extramedullary hematopoietic subcutaneous tumors].
    Soga N; Sakai C; Shibata A; Honma K; Nemoto K
    Rinsho Ketsueki; 1982 Nov; 23(11):1713-8. PubMed ID: 6820087
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy.
    Furukawa F; Sekita K; Hamashima Y; Ozaki M; Imamura S
    Arch Dermatol Res; 1983; 275(3):144-6. PubMed ID: 6604502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune complex glomerulonephritis in leprosy.
    Cöloğlu AS
    Lepr Rev; 1979 Sep; 50(3):213-22. PubMed ID: 522599
    [No Abstract]   [Full Text] [Related]  

  • 31. Serological and immunohistological studies on lepromatous leprosy.
    Kano K; Aranzazu N; Nishimaki T; Convit J; Albini B; Milgrom F
    Int Arch Allergy Appl Immunol; 1981; 64(1):19-24. PubMed ID: 7005119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum immunoglobulin profile and C3 level in lepromatous leprosy patients.
    Harikrishan S; Balakrishnan S; Bhatia VN
    Lepr India; 1982 Jul; 54(3):454-60. PubMed ID: 7176534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG response to some mycobacterial antigens in selected leprosy patients.
    Rafi A
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):567-71. PubMed ID: 10437959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Circulating immune complexes after infectious hepatitis treated with balneotherapy].
    Trvalec V; Klement C; Kurocká J; Lesko A
    Cesk Gastroenterol Vyz; 1981 Aug; 35(6):285-91. PubMed ID: 7273172
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of "high risk group" of leprosy in children using serological and lepromin test: a preliminary report.
    Naik SS; Ganapati R; Shah DH; Dandekar SR; Sahasrabudhe RV
    Indian J Lepr; 1989 Apr; 61(2):173-5. PubMed ID: 2746025
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of circulating immune complexes in leprosy in relation to clinical activity, antileprosy agents, bacterial indices and anti-DNA antibodies].
    Furukawa F; Hamashima Y; Ozaki M
    Nihon Rai Gakkai Zasshi; 1983; 52(2):102-10. PubMed ID: 6678925
    [No Abstract]   [Full Text] [Related]  

  • 38. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
    Hussain R; Dockrell HM; Chiang TJ
    Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating immune complexes in carcinoma of the pancreas.
    Mihas AA; Volanakis JE; Schrohenloher RE; Mihas TA
    Anticancer Res; 1981; 1(3):155-8. PubMed ID: 7342854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocytotoxins in leprosy and in asymptomatic hepatitis B virus infection.
    Serjeantson S; Dry P
    Clin Exp Immunol; 1980 Feb; 39(2):289-96. PubMed ID: 7389201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.